Topical antimicrobials in the control of wound bioburden

Ostomy Wound Management

Volumn 52, Issue 8, 2006, Pages 26-58

  White, Richard J ^a   Cutting, Keith ^a   Kingsley, Andrew ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

ANTIINFECTIVE AGENT; CHLORHEXIDINE; HYPOCHLORITE SODIUM; IODINE DERIVATIVE; PERMANGANATE POTASSIUM; SILVER DERIVATIVE; TOPICAL ANTIINFECTIVE AGENT;

ACUTE DISEASE; BACTERIAL COUNT; BANDAGE; BIOAVAILABILITY; BIOFILM; CHRONIC DISEASE; EVIDENCE BASED MEDICINE; HONEY; HOSPITALIZATION; HUMAN; INFECTION CONTROL; METHODOLOGY; NURSING; QUALITY CONTROL; REVIEW; RISK FACTOR; SKIN CARE; WOUND HEALING; WOUND INFECTION;

ACUTE DISEASE; ANTI-BACTERIAL AGENTS; ANTI-INFECTIVE AGENTS, LOCAL; BANDAGES; BENCHMARKING; BIOFILMS; BIOLOGICAL AVAILABILITY; CHLORHEXIDINE; CHRONIC DISEASE; COLONY COUNT, MICROBIAL; EVIDENCE-BASED MEDICINE; HONEY; HUMANS; INFECTION CONTROL; IODINE COMPOUNDS; POTASSIUM PERMANGANATE; RISK FACTORS; SEVERITY OF ILLNESS INDEX; SILVER COMPOUNDS; SKIN CARE; SODIUM HYPOCHLORITE; WOUND HEALING; WOUND INFECTION;

EID: 33749539453     PISSN: 08895899     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (180)

1. Bowler PG. The 105 bacterial growth guideline: reassessing its clinical relevance in wound healing. Ostomy Wound Manage. 2003;49(1):44-53.
2. Kingsley A. The wound infection continuum and its application to clinical practice. Ostomy Wound Manage. 2003;49(7 suppl A): 1-7.
3. Frank C, Bayoumi I, Westendorp C. Approach to infected skin ulcers. Can Fam Physician. 2005;51:1352-1359. (Pubitemid 41600929)
4. Heinzelmann M, Scott M, Lam T. Factors predisposing to bacterial invasion and infection. Am J Surg. 2002;183:179-190. (Pubitemid 34246432)
5. Cooper R, Lawrence JC. Microorganisms and wounds. J Wound Care. 1996;5(5):233-236.
6. Bowler PG, Duerden BI, Armstrong DG. Wound microbiology and associated approaches to wound management. Clin Micro Rev. 2001;14(2):244-269. (Pubitemid 32294670)
7. Ebright JR. Microbiology of chronic leg and pressure ulcers: clinical significance and implications for treatment. Nurs Clin North Am. 2005;40(2):207-216. (Pubitemid 40744981)
8. Dale JJ, Callam MJ, Ruckley CV, Harper DR, Berry PN. Chronic ulcers of the leg: a study of prevalence in a Scottish community. Health Bulletin. 1983;41:310-314.
9. Edwards R, Harding KG. Bacteria and wound healing. Curr Opin Infect Dis. 2004;17(2):91-96. (Pubitemid 38453386)
10. Leaper DJ. Prophylactic and therapeutic role of antibiotics in wound care. Am J Surg. 1994;167(1 suppl A):15S-19S.
11. Schluter B, Konig W. Microbial pathogenicity and host defense mechanisms - crucial parameters of posttraumatic infections. Thorac Cardiovasc Surg. 1990;38(6):339-347.
12. Thomson PD. Immunology, microbiology, and the recalcitrant wound. Ostomy Wound Manage. 2000;46(1 suppl A):77S-82S.
13. Saffle JR, Schnebly WA. Burn wound care. In: Richard RL, Stanley MJ (eds). Burn Care and Rehabilitation: Principles and Practice. Philadelphia, Pa: Davis Co; 1994:137-139.
14. Ayton M. Wounds that won't heal. Nurs Times. 1985;81(46): 16-19.
15. Cooper RA. Understanding wound infection. In: European Wound Management Association (EWMA) Position Document: Identifying criteria for wound infection. London, UK: MEP Ltd; 2005.
16. Hermans MHE, Bolton LL. How do we manage critically colonized wounds? RehabilNurs. 2004;29(6): 187-194.
17. Sibbald RG, Meaume S, Kirsner RS, Munter KC. Review of the clinical RCT evidence and cost-effectiveness data of a sustained-release silver foam dressing in the healing of critically colonised wounds. Available at: http://www.worldwidewounds.com/2005/december/Sibbald/Silver-Foam-Dressin.... Accessed May 10, 2006.
18. Moore K. Cell biology of chronic wounds: the role of inflammation. J Wound Care. 1999;8 (7):345-348.
19. Cutting KF. The identification of infection in granulating wounds by registered nurses. J Clin Nurs. 1998;7:539-546. (Pubitemid 128705095)
20. Gardner SE, Frantz RA, Doebbeling BN. The validity of the clinical signs and symptoms used to identify localized chronic wound infection. Wound Rep Regen. 2001;9(3):178-186. (Pubitemid 32706264)
21. Cutting KF, White RJ, Mahoney P, Harding KG. Clinical identification of wound infection: a Delphi approach. In: European Wound Management Association (EWMA) Position Document: Identifying criteria for wound infection. London, UK: MEP Ltd;2005.
22. Kingsley A. A proactive approach to wound infection. Nurs Stand. 2001;15(30):50-58.
23. Kingsley A, White R, Gray D, Cooper P. Using the wound infection continuum to assess wound bioburden. Wounds-UK Journal. 2005;1(2 suppl 1): 15-20.
24. Leaper DJ. Prophylactic and therapeutic role of antibiotics in wound care. Am J Surg. 1994;167(1A suppl):15S-20S.
25. Nichols RL. Post operative infections in the age of drug-resistant Gram positive bacteria. Am J Med. 1998;104(5A):11S-16S. (Pubitemid 28299974)
26. Hunt TK. Surgical wound infections: an overview. Am J Med. 1981;70:712-718. (Pubitemid 11153924)
27. Hansis M. Pathophysiology of infection -a theoretical approach. Injury. 1996;27;C5-C8.
28. Mangram AJ, Horan TC, Pearson ML, et al. Guideline for the prevention of surgical site infection. Am J Infect Control. 1999;27(2):97-132.
29. Hunt TK, Hopf HW. Wound healing and wound infection. What surgeons and anaesthesiologists can do. Surg Clin North Am. 1997;77(3):587-606. (Pubitemid 27256036)
30. Haley RW, Culver DH, Morgan WM, et al. Identifying patients at high risk of surgical wound infection: a simple multivariate index of patient susceptibility and wound contamination. Am J Epidemiol. 1985;121:206-215. (Pubitemid 15158532)
31. McGrath DR, McCrory D. An audit of pre-operative skin preparative methods. Ann Roy Coll Surg Eng. 2005; 87(5): 3 66-3 68.
32. Bowler PG, Delargy H, Prince D, et al. The viral barrier properties of some wound dressings and their role in infection control. WOUNDS. 1993;5:1-8.
33. Lawrence JC. Dressings and wound infection. Am J Surg. 1994;167(1 suppl A):21S-24S.
34. Hutchinson JJ, Lawrence JC. Wound infection under occlusive dressings. J Hosp Infect. 1991;17:83-94.
35. Ovington LG. Hanging wet to dry dressings out to dry. Adv Skin Wound Care. 2002;15(2):84-86.
36. Lawrence JC, Lilly HA, Kidson A. Wound dressings and airborne dispersal of bacteria. Lancet. 1992;339:807.
37. Bowler PG, Jones SA, Davies BJ, Coyle E. Infection control properties of some wound dressings. J Wound Care. 1999;8(10):499-502.
38. Newman GR, Walker M, Hobot J, Bowler PG. Visualisation of bacterial sequestration and bactericidal activity within hydrating Hydrofiber wound dressings. Biomaterials. 2006;27(7): 1129 -1139.
39. Serralta VW, Harrison-Balestra C, Cazzaniga AL, et al. Lifestyles of bacteria in wounds: presence of biofilms? WOUNDS. 2000;13(1):29-34.
40. Harrison-Balestra C, Cazzaniga AL, Davis SC. A wound-isolated Pseudomonas aeruginosa grows a biofilm in vitro within 10 hours and is visualized by light microscopy. Dermatol Surg. 2003;29(6):631-635. (Pubitemid 36702450)
41. Percival S. Understanding the effects of bacterial communities and biofilms on wound healing. Available at: http://www.worldwidewounds.com/2004/ july/Percival/Community-Interactions.... Accessed May 10,2006.
42. Hentzer M, Eberl L, Nielsen J, Givskov M. Quorum sensing: a novel target for the treatment of biofilm infections. BioDrugs. 2003;17(4):241-250. (Pubitemid 36999950)
43. Akiyama H, Oono T, Saito M, Iwatsuki K. Assessment of cadexomer iodine against Staphylococcus aureus biofilm in vivo and in vitro using confocal laser scanning microscopy. J Dermatol. 2004;31(7):529-534. (Pubitemid 39045008)
44. Chaw KC, Manimaran M, Tay FEH. Role of silver ions in destabilization of intermolecular adhesion forces measured by atomic force microscopy in Staphylococcus epidermidis biofilms. Antimicrob Agents Chemother. 2005;49(12):4853-4859. (Pubitemid 41778894)
45. Moellering RC. Past, present, and future of antimicrobial agents. Am J Med. 1995;99(6 suppl A):11S-18S.
46. McDonnell G, Russell AD. Antiseptics and disinfectants: activity, action, and resistance. Clin Microbiol Rev. 1999;12(1): 147-179. (Pubitemid 29055958)
47. White RJ, Cooper RA. Silver sulfadiazine. Wounds-UK. 2005; 1(2):51-61.
48. Davis SC, Bouzari N. Development of antimicrobials for wound care: in vitro and in vivo assessments. WOUNDS. 2004; 16(11):344-347. (Pubitemid 39636156)
49. Cooper R. A review of the evidence for the use of topical antimicrobial agents in wound care. World Wide Wounds. Available at: http://www. worldwidewounds.com/2004/february/Cooper/Topical-Antimicrobia.... Accessed February 2, 2006.
50. Wilson JR, Mills JG, Prather ID, Dimitrijevich D. A toxicity index of skin and wound cleansers used on in vitro fibroblasts and keratinocytes. Advances Skin Wound Care. 2005; 18 (7):373-378.
51. Agency for Health Care Policy and Research. Pressure ulcer treatment. Clinical Practice Guidelines Quick Reference Guide. 1994;15:1-25.
52. Cervo FA, Cruz AC, Posillico JA. Pressure ulcers. Analysis of guidelines for treatment and management. Geriatrics. 2000;55(3):55-60.
53. Wipke-Tevis DD, Sae-Sia W. Management of vascular leg ulcers. Adv Skin Wound Care. 2005;18(8):446-447.
54. Cutting KF. A dedicated follower of fashion? Topical medications and wounds. Brit J Nurs. 2001;10(15suppl):9-16.
55. Brennan SS, Leaper DJ. The effects of antiseptics on the healing wound: a study using the rabbit ear chamber. Brit JSurg. 1985;72:780-782. (Pubitemid 16193549)
56. Rodeheaver G. Controversies in topical wound management. WOUNDS. 1989;1:19-27.
57. Lawrence JC. The use of iodine as an antiseptic agent. J Wound Care. 1998;7(8):421-425.
58. Goode PS, Thomas DR. Pressure ulcers. Local wound care. Clin Geriatr Med. 1997;13(3):543 -552.
59. Selkon JB, Cherry GW, Wilson JM, Hughes MA. Evaluation of hypochlorous acid (Sterilox) washes in the treatment of chronic venous leg ulcers. J Wound Care. 2006; 15(1): 1-6.
60. Georgiade NG, Harris WA. Open and closed treatment of burns with povidone iodine. Plast Reconstr Surg. 1973;52(5):640-644.
61. Bianchi J. The cleansing of superficial traumatic wounds. Brit J Nurs. 2000;9(19 suppl):S28-S30.
62. Burks RI. Povidone-iodine solution in wound treatment. Phys Ther. 1998;78:212-218. (Pubitemid 28106239)
63. Kayc ET. Topical antibacterial agents. Infect Dis Clin North Am. 2000;14(2):321-339.
64. Williams C. Irriclens: a sterile wound cleanser in an aerosol can. Br J Nurs. 1996;5(16):1008-1010.
65. Bowler PG. Wound pathophysiology, infection and therapeutic options. Ann Med. 2002;34 (6):419-427. (Pubitemid 36026773)
66. White RJ, Cooper R. The use of topical antimicrobials in wound bioburden control. In: White RJ. The Silver Book. Dinton Wilts, UK: Quay Books:50.
67. Liptak JM. An overview of the topical management of wounds. Austral Vet J. 1997;75(6):408 -413.
68. Gilchrist B. Should iodine be reconsidered in wound management? J Wound Care. 1997;6 (3):148-150.
69. Flynn J. Povidone-iodine as a topical antiseptic for treating and preventing wound infection: a literature review. Brit J Community Nurs. 2003;8(6 Suppl):S36-S42.
70. Parsons D, Bowler PG, Myles V, Jones S. Silver antimicrobial dressings in wound management: a comparison of antibacterial, physical, and chemical characteristics. WOUNDS. 2005;17(8):222-232. (Pubitemid 41305917)
71. White RJ, Molan P. A summary of published clinical research on honey in wound management. In: White RJ, Cooper RA, Molan P (eds). Honey: A Modern Wound Management Product. Aberdeen, Scotland: Wounds-UK Publishing;2005.
72. Drosou A, Falabella A, Kirsner RS. Antiseptics on wounds: an area of controversy. WOUNDS. 2003;15(5):149-166. (Pubitemid 36886581)
73. Mertz PM, Oliviera-Gandia MF, Davis S. The evaluation of a cadexomer iodine wound dressing on methicillin-resistant Staphylococcus aureus (MRSA) in acute wounds. Dermatol Surg. 1999;25(2):89-93. (Pubitemid 30195943)
74. McLure AR, Gordon J. In vitro evaluation of povidone-iodine and Chlorhexidine against methicillin-resistant Staphylococcus aureus. J Hosp Infect. 1992;21:291-299.
75. Lawrence JC. A povidone-iodine medicated dressing. J Wound Care. 1998;7(7):332-336.
76. Ellenhorn JD, Smith DD, Schwarz RE, Kawachi MH, Wilson TG, McGonigle KF. Paint-only is equivalent to scrub-and-paint in preoperative preparation of abdominal surgery sites. J Am Coll Surg. 2005;201(5):737-741. (Pubitemid 41539767)
77. Thomas C. Nursing alert -wound healing halted with the use of povidone iodine. Ostomy Wound Manage. 1988;18:30-33.
78. Goldenheim PD. An appraisal of povidone-iodine and wound healing. Postgrad Med J. 1993;69(Suppl):S97-S105. (Pubitemid 23317413)
79. Gulliver G. Arguments over iodine. Nurs Times. 1999;95(27):68-70.
80. Sundberg J, Meiler R. A retrospective review of the use of cadexomer iodine in the treatment of chronic wounds. WOUNDS. 1997;9(3):68-86.
81. Topical antimicrobial drug products for over the counter human use; tentative final monograph for health care antiseptic drug products. Federal Register. June 17,1994;58:116.
82. Kramer SA. Effect of povidone-iodine on wound healing: a review. J Vase Nurs. 1999; 17 (1):17-23.
83. Lineaweaver W, McMorris S, Soucy D, Howard R. Cellular and bacterial toxicities of topical antiseptic. PlastReconstruc Surg. 1985;75:394-396. (Pubitemid 15143599)
84. Wright JB, Lam K, Burrell RE. Wound management in an era of increasing bacterial antibiotic resistance: a role for topical silver treatment. Am J Infect Control. 1998;26(6):572-577. (Pubitemid 28565074)
85. Russell AD, Hugo WB. Antimicrobial activity and action of silver. Prog Med Chem. 1994;31:351-370.
86. Cervantes C, Silver S. Metal resistance m Pseudomonas genes and mechanisms. In: Nakazawa T, Furakawa K, Haas D, Silver S eds. Molecular Biology ofPseudomonads. Washington, DC: American Society for Microbiology; 1996.
87. Demling RH, DeSanti L. The role of silver in wound healing. Part 1 : Effects of silver on wound management. WOUNDS. 2001;13(1 suppl): A3-A1 5.
88. Guggenbichler JP, Boswald M, Lugauer S, Krall T. A new technology of microdispersed silver in polyurethane induces antimicrobial activity in central venous catheters. Infection. 1999;27(1 suppl):S16-S23. (Pubitemid 29255570)
89. Pruitt BA. Opportunistic infections in burn patients: diagnosis and treatment. In: Root R, Trunkey R, Sande MA (eds). New Surgical and Medical Approaches to Infectious Diseases. New York, NY: Churchill Livingstone; 1987:245-261.
90. Buckley SC, Scott K, Das K. Late review of the use of silver sulphadiazine dressing for the treatment of fingertip injuries. Injury Int J Care Injured. 2000;31:301-304. (Pubitemid 30206973)
91. Bishop JB, Phillips LG, Mustoe TA, et al. A prospective randomized evaluator-blinded trial of two potential wound healing agents for the treatment of venous stasis ulcers. J Vase Surg. 1992;16:251-257.
92. Modak SM, Fox CL. Sulfadiazine silver-resistant Pseudomonas in burns. Arch Surg. 1981;116:854-857.
93. O'Meara SO, Cullum N, Majid M, Sheldon T. Systematic reviews of wound care management: (3) Antimicrobial agents. Health Technol Assess. 2000;4(21): 1-237.
94. O'Meara SO, Cullum N, Majid M, Sheldon T. Systematic review of antimicrobial agents used for chronic wounds. Brit J Surg. 2001;88:4-21. (Pubitemid 32066051)
95. Furr JR, Russell AD, Turner TD, Andrews A. Antibacterial activity of Actisorb Plus, Actisorb and silver nitrate. J Hosp Infect. 1994;27:201-208. (Pubitemid 24241398)
96. Wright JB, Hansen DL, Burrell RE. The comparative efficacy of two antimicrobial barrier dressings: in vitro examination of two controlled release silver dressings. WOUNDS. 1998; 10:179 -188.
97. Jones SA, Bowler PG, Walker M, Parsons D. Controlling wound bioburden with novel silvercontaining hydrofibre dressing. Wound Rep Regen. 2004;12(3):288-294. (Pubitemid 38880437)
98. Bowler PG, Jones SA, Walker M, Parsons D. Microbicidal properties of a silver-containing hydrofibre dressing against a variety of burn wound pathogens. J Burn Care Rehab. 2004;25 (2): 192-196. (Pubitemid 38296042)
99. Kumar R, Munstedt H. Silver ion release from antimicrobial polyamide/silver composites. Biomaterials. 2005;26(14):20S 1-2088.
100. Bergin SM, Wraight P. Silver-based wound dressings and topical agents for treating diabetic foot ulcers. The Cochrane Database of Systematic Reviews. 2006;1(CD005082).2.
101. The University of Sheffield. Antimicrobial dressings for venous leg ulcers. The VULCAN Trial. Available at: http : //www.shef.ac.uk/dcsn/research/ cardiovascular/vascular-surgery/vulcan. Accessed February 4, 2006.
102. O'Neill MA, Vine GJ, Beezer AE, et al. Antimicrobial properties of silver-containing wound dressings: a microcalorimetric study. Int J Pharm. 2003;263(1-2):61-68. (Pubitemid 37087933)
103. Lansdown AB, Jensen K, Jensen M. Contreet foam and Contreet hydrocolloid: an insight into two new silver dressings. J Wound Care. 2003;12(6):205.
104. Meaume S, Vallet D, Morere MN, Teot L. Evaluation of a silver-releasing hydroalginate dressing in chronic wounds with signs of local infection. J Wound Care. 2005;14(10):479-483.
105. Caruso DM, Foster KN, Hermans MH, Rick C. Aquacel Ag in the management of partialthickness burns: results of a clinical trial. J Burn Care Rehab. 2004;25(1):89-97. (Pubitemid 38116761)
106. Russell AD. Introduction of biocides into clinical practice and the mpact on antibioticresistant bacteria. J Appl Microbiol. 2002;92(suppl):21S-35S.
107. Cookson BD, Bolton MC, Platt JH. Chlorhexidine resistance in methicillin-resistant Staphylococcus aureus or just an elevated MIC? An in vitro and in vivo assessment. Antimicrob Agents Chemother. 1991;35(10): 1997-2002.
108. Scott Ward R, Saffle JR. Topical agents in burn wound care. Phys Ther. 1995;75(6):526-538.
109. Lambert PM, Moris HF, Ochi S. The influence of 0.12% Chlorhexidine gluconate rinses on the incidence of infectious complications and implant success. J Oral Maxillofacial Surg. 1997;55 (12 suppl 5):25-30. (Pubitemid 27515002)
110. Krebs FC, Miller SR, Ferguson ML, et al. Polybiguanides, particularly polyeyhylene hexamethylene biguanide, have activity against human immunodeficiency virus type 1. Biomed Pharmacother. 2005;59(8):438-445. (Pubitemid 41383837)
111. Schmit-Neuerburg KP, Bettag Ch, Schlickewei W, et al. Wirksamkeit eines neuartigen Antisepticum in der Behandlung kontaminierter Weichteilwunden. Chirug. 2001;72:61-71. (Pubitemid 33681889)
112. Fernandez R, Griffiths R, Ussia C. Water for wound cleansing. The Cochrane Database of Systematic Reviews. 2002;4.
113. Cooper RA, Molan PC, Harding KG. The sensitivity to honey of Gram-positive cocci of clinical significance isolated from wounds. J Appl Microbiol. 2002;93(5):857-863. (Pubitemid 35340889)
114. Molan P. The role of honey in the management of wounds. J Wound Care. 1999;8(8):415-418.
115. Dunford C, Cooper R, Molan P, White RJ. The use of honey in wound management. Nurs Stand. 2000; 15(11):63-68.
116. Kingsley A. The use of honey in the treatment of infected wounds: case studies. Brit J Nurs. 2001; 10(20 suppl): S13-S20.
117. Anderson I. Should potassium permanganate be used in wound care? Nurs Times. 2003;99 (31):61.
118. Roe B, Cullum N. The management of leg ulcers: current nursing practice. In: Cullum N, Roe B (eds). Leg Ulcers: Nursing Management. A Research-based Guide. London, UK: Scutari Press; 1995.
119. Anon. Potassium permanganate. J Wound Care. 2000;9(9):420.
120. Leaper DJ. Eusol. Brit Med J. 1992;304:930-931.
121. Moore D. Hypochlorites: a review of the evidence. J Wound Care. 1992;1(4):44-53.
122. Kozol RA, Gillies C, Elgebaly SA. Effects of sodium hypochlorite (Dakin's solution) on cells of the wound module. Arch Surg. 1988;123:420-423.
123. Cotter JL, Fader RC, Lilley C, Herndon DN. Chemical parameters, antiseptic activities and tissue toxicity of 0.1 and 0.5% sodium hypochlorite solutions. Antimicrob Agents Chemother. 1985;28:118-122. (Pubitemid 15029704)
124. Roe BH, Luker KA, Cullum NA, Griffiths JM, Kenrick M. Nursing treatment of patients with chronic leg ulcers in the community: report of a survey. J Clin Nurs. 1994;3(3): 159-168.
125. Leaper DJ. Antiseptic toxicity in open wounds. Nurs Times. 1988;84(25):77-79.
126. Lindfors JA. Comparison of an antimicrobial wound cleanser to normal saline in reduction of bioburden and its effect on wound healing. Ostomy Wound Manage. 2004;50(8):28-41.
127. Milner SM. Acetic acid to treat Pseudomonas aeruginosa in superficial wounds and burns. Lancet. 1992;34:61.
128. Bennett LL, Rosenblum RS, Perlov C, et al. An in vivo comparison of topical agents on wound repair. Plast Reconstr Surg. 2001;108:675-687.
129. Eron LJ, Lipsky BA, Low DE, et al. Managing skin and soft tissue infections: expert panel recommendations on key decision points. J Antimicrob Chemother. 2003;52(suppl):S1 i3-Sl i17.
130. Local applications to wounds: 1. Cleansers, antibacterials, debriders. Drug and Therapeutics Bulletin. 1991;29(24): 93-95.
131. Zaki I, Shall L, Dalziel KL. Bacitracin: a significant sensitiser in leg ulcer patients? Contact Dermatitis. 1994;31:92-94. (Pubitemid 24220985)
132. Darsow U, the European Task Force on Atopic Dermatitis. Position paper on diagnosis and treatment of atopic dermatitis. J Eur Acad Dermatol. 2005;19(3):286-295. (Pubitemid 40691704)
133. Topical antibiotics (Anonymous Editorial). BMJ. 1977;1:494.
134. Colsky AS, Kirsner R, Kerdel F. Analysis of antibiotic susceptibilities of skin flora in hospitalised dermatology patients. The crisis of antibiotic resistance has come to the surface. Arch Dermatol. 1998;134:1006-1009. (Pubitemid 28385324)
135. Epstein BJ, Gums JG, Drlica K. The changing face of antibiotic prescribing. Anns Pharmacother. 2004;38:1675-1682.
136. Alinovi A, Bassissi P, Pini M. Systemic administration of antibiotics in the management of venous ulcers. J Am Acad Dermatol. 1986;15:186-191. (Pubitemid 16070344)
137. Huovinen S, Kotilainen P, Jarvinen H, et al. Comparison of ciprofloxacin or trimethoprim therapy for venous leg ulcers: results of a pilot study. J Am Acad Dermatol. 1994;31:279-281. (Pubitemid 24242872)
138. Fraki JE, Peltonen L, Hopsu-Havu VK. Allergy to various components of topical preparations in stasis dermatitis and leg ulcer. Contact Derm. 1979;5(2):97-100. (Pubitemid 9148833)
139. Clark J. Metronidazole gel in managing malodorous fungating wounds. Br J Nurs. 2002; 11(6 Suppl):S54-S60.
140. Scottish Intercollegiate Guidelines Network. The Care of Patients with Chronic Leg Ulcer. A National Clinical Guideline. Edinburgh, Scotland: Royal College of Physicians. Available at: http://www.show.cee.hw.ac.uk/sign/home.htm. Accessed February 10, 2006.
141. Foster A, McColgan M, Edmonds M. Should oral antibiotics be given to "clean" foot ulcers with no cellulitis? Abstract 27. Diabet Med. 1998;15(suppl 2):S10.
142. Bandmann HJ, Breit R.The mafenide story. Br J Dermatol. 1973;89(2):219-221.
143. Palmieri TL, Greenhalgh DG. Topical treatment of pediatric patients with burns: a practical guide. Am J Clin Dermatol. 2002;3(8):529-534. (Pubitemid 35252503)
144. Barillo DJ. Using mafenide acetate in acute and chronic wounds. Ostomy Wound Manage. 2002;48(9 suppl):5-10.
145. Nanney LB, Bennett LL. Comparative evaluation of topical antiseptic/antimicrobial treatment on aspects of wound repair in the porcine model. Ostomy Wound Manage. 2002;48 (9 suppl): 14-19.
146. Krob HA, Fleischer AB, D'Agostino R, et al. Prevalence and relevance of contact dermatitis allergens: a meta-analysis of 15 years of published TRUE test data. J Am Acad Dermatol. 2004;51 (3):349-353. (Pubitemid 39178659)
147. Marks JG, Belsito DV, DeLeo VA, Fowler JF. North American contact dermatitis group patch test results for the detection of delayed-type hypersensitivity to topical allergens. J Am Acad Dermatol. 1998;38(6 part 1):911-918. (Pubitemid 28299182)
148. Cameron J, Wilson C, Powell S, et al. Contact dermatitis in leg ulcer patients. Ostomy Wound Manage. 1992;3 8(9): 8-11.
149. Tavadia S, Bianchi J, Dawe RS, McEvoy M, et al. Allergic contact dermatitis in venous leg ulcer patients. Contact Derm. 2003;48(5):261-265. (Pubitemid 36960360)
150. Wertheim HF, Verveer J, Boelens HA, et al. Effect of mupirocin treatment on nasal, pharyngeal, and perineal carriage of Staphylococcus aureus in healthy adults. Antimicrob Agents Chemother. 2005;49(4): 1465-1467. (Pubitemid 40463377)
151. Fawley WN, Parnell P, Hall J, Wilcox MH. Surveillance for mupirocin resistance following introduction of routine peri-operative prophylaxis with nasal mupirocin. J Hosp Infect. 2005;Dec (E-publication ahead of print).
152. Rahman M, Noble W, Cookson B. Mupirocin-resistant Staphylococcus aureus (letter). Lancet. 1987;August 15;387.
153. Kluytman JA, Wertheim HJ. Nasal carriage of Staphylococcus aureus and prevention of nosocomial infections. Infection. 2005;33(1):3-8.
154. Atkins B, Gottlieb T. Fusidic acid in bone and joint infections. Int J Antimicrob Agents. 1999;12(suppl2):S79-S93. (Pubitemid 29406145)
155. Ravenscroft J, Layton A, Barnham M. Observations on high levels of fusidic acid resistant Staphylococcus aureus in Harrogate, North Yorkshire, UK. Clin Exp Dermatol. 2000;25:323-326.
156. Mason BW, Howard BJ, Magee JT. Fusidic acid resistance in community isolates of methicillin-susceptible Staphylococcus aureus and fusidic prescribing. J Antimicrob Chemother. 2003;51:1033-1036. (Pubitemid 36503442)
157. Jones RN, Li Q, Kohut B, Biedenbach DJ, Bell J, Turnidge JD. Contemporary antimicrobial activity of triple antibiotic ointment: a multiphased study of recent clinical isolates in the United States and Australia. Diagn Microbiol Infect Dis. 2006;54(1):63-71. (Pubitemid 41815190)
158. Grandinetti PJ, Fowler JF. Simultaneous contact allergy to neomycin, bactitracin, and polymyxin. J Am Acad Dermatol. 1990;23(4 part 1):646-647. (Pubitemid 20336389)
159. Sood A, Taylor JS. Bacitracin: allergen of the year. Am J Contact Dermat. 2003;14(1):3-4. (Pubitemid 36992628)
160. Cutting KF. The causes and prevention of maceration of the skin. J Wound Care. 1999;8 (4):200-202.
161. Hall Angeras M, Brandberg A, Falk A, Seeman T. Comparison between sterile saline and tap water for the acute traumatic soft tissue wounds. Eur J Surg. 1992;158:147-150.
162. Chrintz H, Vibits H, Harreby J, et al. Discontinuing post operative wound dressings. Brit J Surg. 1989;76(2):204-205.
163. Oliver L. Wound cleansing. Nurs Stand. 1997;11(20):44-51.
164. Moore ZEH, Cowman S. Wound cleansing for pressure ulcers. The Cochrane Database of Systematic Reviews (2005), Issue 4. Art. No.: CD004983.pub2.
165. Bowler PG, Davies BJ, Jones SA. Microbial involvement in chronic wound malodour. J Wound Care. 1999;8(10):216-218
166. Thomas S, Fisher B, Fram PJ, Waring MJ. Odour-absorbing dressings. J Wound Care. 1998;7(5):246-250.
167. Haughton W, Young T. Common problems in wound care: malodorous wounds. Brit J Nurs. 1995;4(16):959-963.
168. Rice TT. Metronidazole use in malodorous skin lesions. J Rehab Nurse. 1992;17(5):244-255.
169. Fraise AP, Mitchell K, O'Brien SJ, et al. Methicillin-resistant Staphylococcus aureus in nursing homes in a major UK city: an anonymised point prevalence study. Epidemiol Infect. 1997;118:1-5. (Pubitemid 27095719)
170. Cookson BD. Methicillin-resistant Staphylococcus aureus in the community: new battlefronts, or are the battles lost? Infect Control Hosp Epidemiol. 2000;21(6): 3 98-403.
171. Valencia IC, Kirsner RS, Kerdel FA. Microbiologic evaluation of skin wounds: alarming trend towards antibiotic resistance in an inpatient dermatology service during a ten-year period. J Am Acad Dermatol. 2004;50(6):845-849. (Pubitemid 38685761)
172. Trengove N, Stacey M, McGechie D, et al. Qualitative bacteriology and leg ulcer healing. J Wound Care. 1996;5(6):277-280.
173. Gilchrist B. Wound infection. In: Miller M, Glover D (eds). Wound Management. London, UK: NT Books; 1997.
174. Leaper DJ. Defining infection (Editorial). J Wound Care. 1998;7(8):373.
175. Thompson PD, Smith DJ. What is infection? Am J Surg. 1994;167:(1 suppl A):7S-11S.
176. Cooper R, Lawrence JC. The prevalence of bacteria and implications for infection control. J Wound Care. 1996;5(6):291-295.
177. Robson MC. Lessons gleaned from the sport of wound watching. Wound Repair Regen. 1999;7(1):1-6.
178. Ennis WJ, Meneses P. Wound healing at the local level: the stunned wound. Ostomy Wound Manage. 2000;46(1 suppl A):39S-50S.
179. Pierard-Franchimont C, Quatresooz P, Paquet P, et al. How I treat the critical bacterial colonization of a leg ulcer. The Yin and Yang features of silver-based dressings. Rev Med Liege. 2004;59(6):403-406. (Pubitemid 38937799)
180. Halbert AR, Stacey MC, Rohr JB, Jopp-McKay A. The effect of bacterial colonisation on venous ulcer healing. Aust J Dermatol. 1992;33:75-80.